Key facts
- GEM Health’s last known valuation is $60.0M (Oct 2022).
- It has raised $22.5M across 1 recorded rounds; the latest was Early Stage VC ($10.5M) in Apr 2021.
- Notable investors include Mana Ventures, Soma Capital, Collaborative Fund, S2G Investments, Barrel Ventures — 17 tracked in total.
- GEM Health has filed 1 Form D with the SEC, most recently Jun 2021 ($10.5M sold to 37 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for GEM Health
Funding rounds
1 roundsAbout GEM Health
Producer of nutritional supplements intended for daily wellness support. The company offers a chewable, plant-based formula containing essential vitamins, minerals, probiotics, and antioxidants sourced from natural ingredients, enabling individuals to maintain balanced nutrition, support immune health, improve digestion, enhance energy levels, and promote overall well-being.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Los Angeles, CA, United States
- Founded
- 2018
- Employees
- 21
- Website
- dailygem.com/
- Ownership
- Privately Held (backing)
GEM Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in GEM Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on GEM Health in its N-PORT filings yet. We sweep new filings monthly.